Transfection reagent, TransIT®-BrCa
Supplier: MIRUS
TransIT®-BrCa transfection reagent offers superior DNA transfection of breast cancer cell types.
- Achieve high expression levels in multiple breast cancer cell types
- Formulated for low cellular toxicity – maintain cell density and reduce experimental bias
- Superior transfection efficiency
TransIT®-BrCa transfection reagent is a dedicated breast cancer cell line specific reagent. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental bias. TransIT®-BrCa transfection reagent exhibits higher luciferase expression in breast cancer cells compared to other transfection reagents.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...